With Zepbound approved for sleep apnea, Lilly spends up to $7.8 billion for a company with a narcolepsy drug

Eli Lilly is spending up to $7.8 billion to buy Centessa, which is working on treatments for sleep-wake disorders. Eli Lilly has made yet another deal, this time buying a drug company that's ...

What exactly are GLP-1 medications and how do they work?

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
North Country Public Radio

How to navigate the maze of drug discounts to get the best price

In February, TrumpRx joined a growing list of websites consumers can tap for discounts on their medicines. Here's a cheat sheet for getting the... How to navigate the maze of drug discounts to get the ...

Novo Nordisk: A Comeback Story In The World's Fastest-Growing Drug Market

Novo Nordisk is positioned as a durable No. 2 in the obesity drug market, not a loser to Eli Lilly. Click here to read an ...

Why tirzepatide is better than semaglutide, GLP-1 medication guide

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...